Alx Oncology Holdings ALXO
NASDAQ ALXO
$1.22 -0.08 (-6.15%)
At close: Oct 2, 2026 · 4:00 PM EDT

Alx Oncology Holdings (ALXO) Depreciation & Amortization (CF) (2019 - 2026)

Updated

Alx Oncology Holdings (ALXO) reported Depreciation & Amortization (CF) of $86,000 for Q2 2026, down 55.0% from $191,000 a year earlier and down 42.7% from the prior quarter.

Analysis

Alx Oncology Holdings (ALXO) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Alx Oncology Holdings' Depreciation & Amortization (CF) came in at $540,000, down 35.7% year-over-year; for FY2025, it came in at $706,000, down 19.0% from FY2024.

  • Depreciation & Amortization (CF) has a five-year compound annual growth rate of 28.4% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $872,000 in FY2024 (+4.3%), $836,000 in FY2023 (+144.4%), $342,000 in FY2022 (+570.6%) and $51,000 in FY2021 (-74.8%).
  • The Q2 2026 figure ranks as the lowest quarterly Depreciation & Amortization (CF) since Q2 2022.
  • Year over year, Depreciation & Amortization (CF) has now declined in each of the last six quarters, with an average decline of 18.6% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q4 2021 (growth of 580.0%); the low point was Q2 2026 (a decline of 55.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $150,000 (Q1 2026), $151,000 (Q4 2025) and $153,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 1.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.93 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 1.62 Bn
10 Alx Oncology Holdings 168.62 Mn 168.62 Mn - 86,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 86,000.00
Mar 31, 2026 150,000.00
Dec 31, 2025 151,000.00
Sep 30, 2025 153,000.00
Jun 30, 2025 191,000.00
Mar 31, 2025 211,000.00
Dec 31, 2024 214,000.00
Sep 30, 2024 224,000.00
Jun 30, 2024 220,000.00
Mar 31, 2024 214,000.00
Dec 31, 2023 207,000.00
Sep 30, 2023 209,000.00
Jun 30, 2023 207,000.00
Mar 31, 2023 213,000.00
Dec 31, 2022 105,000.00
Sep 30, 2022 95,000.00
Jun 30, 2022 84,000.00
Mar 31, 2022 58,000.00
Dec 31, 2021 34,000.00
Sep 30, 2021 6,000.00
API Access

Alx Oncology Holdings Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ALXO&period=max&api_key=YOUR_API_KEY